Obesity Medication Use Remains Low Among Children | ADA 2025
Drug Topics
JUNE 25, 2025
from 2017 to 2020. Authors of a Journal of the American Medical Association study found that adolescent use of GLP-1s “increased substantially” between 2020 and 2023. of YA with obesity were prescribed OMs—predominantly GLP-1s approved for adults but used off label for younger people. of adolescents and 5.7% April 2, 2024.
Let's personalize your content